At Delta4, we empower pharma and biotech companies throughout their entire drug development journey – from early target discovery and disease- or drug-centric repositioning to side effect prediction, biomarker identification, and clinical trial design.
Contact us to find out more about how you can invest with us and be a part of pioneering the next successful treatment.
We ensure that our discoveries go beyond theoretical AI extrapolations and are followed through to real-world applications.
Scientist.com provides a unique platform where researchers and suppliers can both find each other and work together more easily. They provide a collaboration framework to streamline the typically long and tedious process of defining the terms and conditions of an agreement.
Members can work together smoothly and effortlessly by agreeing to the rules of the platform. The result is that together we can achieve the results we need faster.
“Delta4’s AI-Powered Hyper-C Platform Uncovers New Drug Indications, Expanding Treatment Potential for Iguratimod” – As Featured on Scientist.com
